José María Prieto-González

9PUBLICATIONS
39CO-AUTHORS
Neurology and neuromuscular diseasesCardiology (incl. cardiovascular diseases)Medical molecular engineering of nucleic acids and proteinsGene and molecular therapyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 12, 2026
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.

|Feb 13, 2026
Reduced Plasma Aβ Peptides but Stable NfL and GFAP in Major Depressive Disorder.

María de Los Ángeles Fernández-Ceballos, Lara Vidal-Nogueira, Carlos Fernández-Pereira

|Jan 30, 2026
Multiparametric assessment of atrial cardiopathy in cryptogenic stroke patients: Implications for personalized clinical management.

Iria López-Dequidt, Sonia Eiras-Penas, Adrián González-Maestro

|Sep 24, 2025
Multiparametric assessment of atrial cardiopathy in cryptogenic stroke patients: Implications for personalized clinical management.

Iria López-Dequidt, Sonia Eiras-Penas, Adrián González-Maestro

|Jul 16, 2024
Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors.

Silvia Campanioni, César Veiga, José María Prieto-González

|Dec 09, 2023
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.

Agustín Sancho-Saldaña, Anna Gil-Sánchez, Cristina González-Mingot

Pageof 2

Frequent Collaborators

5 joint publications

Roberto Carlos Agís-Balboa

2 joint publications

Daniel Pérez-Rodríguez

2 joint publications

Sonia Eiras-Penas

2 joint publications

Amparo Martínez-Monzonís